Live Quote · NYSEBDXHealthcare· Medical - Instruments & Supplies

Becton, Dickinson and Company

$158.17▼ 1.10%($-1.76)
TickerSpark Score
64/100
▌ Mixed
76
Valuation
65
Profitability
40
Growth
60
Health
80
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BDX research report →

52-Week Range51% of range
Low
$127.59
Current
$158.17
High
$187.35
Company Overviewwww.bd.com

About the company

Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world.

CEO
Thomas E. Polen Jr.
IPO
1973
Employees
72,000
HQ
Franklin Lakes, NJ, US

Price Chart

+11.22% · this period
$185.39$160.46$135.54Jul 17Jan 15Jul 17

Get TickerSpark's AI analysis on BDX

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in